Loading...

Sarah Doernberg, MD, MAS

TitleAssistant Professor
SchoolUCSF School of Medicine
DepartmentMedicine
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoM.A.S. in Clinical Research2012 Graduate Division (Advance Training in Clinical Research)
    University of California, San FranciscoFellowship2012Infectious Diseases
    University of California, San Francisco Residency 2009Internal Medicine
    Yale UniversityM.D.2006School of Medicine

    Collapse Overview 
    Collapse Overview
    Sarah Doernberg is an Assistant Clinical Professor of Medicine in the Division of Infectious Diseases and the Medical Director of Adult Antimicrobial Stewardship at UCSF Medical Center. She has an active outpatient Infectious Diseases Clinic and sees inpatients on the Transplant Infectious Diseases service. Her clinical research focuses on healthcare-acquired infections and antimicrobial stewardship.

    She received her BA from Harvard University in Biology with a focus in Neurobiology and received her MD from Yale University School of Medicine. She completed her Internal Medicine residency and Infectious Diseases fellowship at UCSF. She also received a Masters’ degree in advanced studies through the Training in Clinical Research Program at UCSF.


    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Global Health

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Doernberg S, Chambers HF. Antimicrobial Stewardship Approaches in the Intensive Care Unit. Infect Dis Clin North Am. 2017 Sep; 31(3):513-534. PMID: 28687210.
      View in: PubMed
    2. Doernberg S, Lodise TP, Thaden JT, Munita JM, Cosgrove SE, Arias CA, Boucher HW, Corey GR, Lowy FD, Murray B, Miller LG, Holland TL. Gram-Positive Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group. Clin Infect Dis. 2017 Mar 15; 64(suppl_1):S24-S29. PMID: 28350900.
      View in: PubMed
    3. Brondfield MN, Reid MJ, Rutishauser RL, Cope JR, Tang J, Ritter JM, Matanock A, Ali I, Doernberg S, Hilts-Horeczko A, DeMarco T, Klein L, Babik JM. Disseminated Acanthamoeba infection in a heart transplant recipient treated successfully with a miltefosine-containing regimen: Case report and review of the literature. Transpl Infect Dis. 2017 Apr; 19(2). PMID: 28067969.
      View in: PubMed
    4. Baxi SM, Robinson ML, Grill MF, Schwartz BS, Doernberg S, Liu C. Clinical Characteristics and Outcomes Among Individuals With Spinal Implant Infections: A Descriptive Study. Open Forum Infect Dis. 2016 Sep; 3(3):ofw177. PMID: 27704027.
      View in: PubMed
    5. Baxi SM, Clemenzi-Allen A, Gahbauer A, Deck D, Imp B, Vittinghoff E, Chambers HF, Doernberg S, et al. Vancomycin MIC Does Not Predict 90-Day Mortality, Readmission, or Recurrence in a Prospective Cohort of Adults with Staphylococcus aureus Bacteremia. Antimicrob Agents Chemother. 2016 Sep; 60(9):5276-84. PMID: 27324762; PMCID: PMC4997864 [Available on 03/01/17].
    6. Pollett S, Baxi SM, Rutherford GW, Doernberg S, Bacchetti P, Chambers HF, et al. Cefazolin versus Nafcillin for Methicillin-Sensitive Staphylococcus aureus Bloodstream Infection in a California Tertiary Medical Center. Antimicrob Agents Chemother. 2016 Aug; 60(8):4684-9. PMID: 27216053; PMCID: PMC4958157 [Available on 02/01/17].
    7. Doernberg S, Dudas V, Trivedi KK. Implementation of an antimicrobial stewardship program targeting residents with urinary tract infections in three community long-term care facilities: a quasi-experimental study using time-series analysis. Antimicrob Resist Infect Control. 2015; 4:54. PMID: 26634119; PMCID: PMC4667475.
    8. Doernberg S, Winston LG, Deck DH, Chambers HF. Does doxycycline protect against development of Clostridium difficile infection? Clin Infect Dis. 2012 Sep; 55(5):615-20. PMID: 22563022; PMCID: PMC3491851.
    9. Doernberg S, Winston LG. Risk factors for acquisition of extended-spectrum ß-lactamase-producing Escherichia coli in an urban county hospital. Am J Infect Control. 2012 Mar; 40(2):123-7. PMID: 21775020.
      View in: PubMed
    10. Doernberg S, Schaaf B, Dalhoff K, Leng L, Beitin A, Quagliarello V, Bucala R. Association of macrophage migration inhibitory factor (MIF) polymorphisms with risk of meningitis from Streptococcus pneumoniae. Cytokine. 2011 Mar; 53(3):292-4. PMID: 21208809; PMCID: PMC3033983.
    11. Doernberg S, Bucala R . The Macrophage in Innate and Adaptive Immunity. In: Critical Care Nephrology, 2nd Ed. 2009; 784-788.
    12. Bucala R, Leng L, Doernberg S, Bukrinsky M, Donnelly S. MIF Agonists and Antagonists and Therapeutic Uses Thereof. World Patent WO 2006/116688. 2006.
    13. McNally, K, Davis, K, Doernberg, S, Zubal I, Spencer S, Blumenfeld H. Cerebral Blood Flow Changes During Secondarily Generalized Tonic-Clonic Seizures. Abstract and poster. Society for Neuroscience Annual Meeting, San Diego, CA. 2004.
    14. McNally KA, Vanderhill SD, Paige AL, Doernberg S, Chung R, Adamiak K, Novotny EJ, Zubal IG, Spencer SS, and Blumenfeld H. Excitatory and Inhibitory Network Interactions During Loss of Consciousness in Temporal Lobe Epilepsy. The American Epilepsy Society, Boston, MA. 2003.
    15. McNally KA, Vanderhill S, Paige AL, Doernberg S, Chung R, Adamiak K, Novotny EJ, Zubal IG, Spencer SS, Blumenfeld H. Network Mechanisms for Loss of Consciousness in Temporal Lobe Epilepsy. Society for Neuroscience Annual Meeting, New Orleans, LA. 2003.
    Sarah's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP